These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 29034744)

  • 1. Correction to Oncogenic osteomalacia: role of Ga-68 DOTANOC PET/CT scan in identifying the culprit lesion and its management.
    Singh D; Chopra A; Ravina M; Kongara S; Bhatia E; Kumar N; Gupta S; Yadav S; Dabadghao P; Yadav R; Dube V; Kumar U; Dixit M; Gambhir S
    Br J Radiol; 2017 Nov; 90(1079):20160811e. PubMed ID: 29034744
    [No Abstract]   [Full Text] [Related]  

  • 2. Oncogenic osteomalacia: role of Ga-68 DOTANOC PET/CT scan in identifying the culprit lesion and its management.
    Singh D; Chopra A; Ravina M; Kongara S; Bhatia E; Kumar N; Gupta S; Yadav S; Dabadghao P; Yadav R; Dube V; Kumar U; Dixit M; Gambhir S
    Br J Radiol; 2017 Apr; 90(1072):20160811. PubMed ID: 28181822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic osteomalacia: exact tumor localization by co-registration of positron emission and computed tomography.
    Hesse E; Moessinger E; Rosenthal H; Laenger F; Brabant G; Petrich T; Gratz KF; Bastian L
    J Bone Miner Res; 2007 Jan; 22(1):158-62. PubMed ID: 17014386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of Gallium-68 DOTANOC PET/CT in the localization of Tumour-induced osteomalacia.
    Bhavani N; Reena Asirvatham A; Kallur K; Menon AS; Pavithran PV; Nair V; Vasukutty JR; Menon U; Kumar H
    Clin Endocrinol (Oxf); 2016 Jan; 84(1):134-40. PubMed ID: 25996566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful localization of residual culprit tumor in a case of tumor-induced osteomalacia using 68Ga-DOTANOC PET/CT.
    Naswa N; Sharma P; Kumar R; Malhotra A; Bal C
    Clin Nucl Med; 2013 Aug; 38(8):639-40. PubMed ID: 23531775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.
    Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME
    J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 68Ga-DOTANOC PET/CT clinical impact in patients with neuroendocrine tumors.
    Ambrosini V; Campana D; Bodei L; Nanni C; Castellucci P; Allegri V; Montini GC; Tomassetti P; Paganelli G; Fanti S
    J Nucl Med; 2010 May; 51(5):669-73. PubMed ID: 20395323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin receptor expression in lymphomas: a source of false diagnosis of neuroendocrine tumor at
    Ruuska T; Ramírez Escalante Y; Vaittinen S; Gardberg M; Kiviniemi A; Marjamäki P; Kemppainen J; Jyrkkiö S; Minn H
    Acta Oncol; 2018 Feb; 57(2):283-289. PubMed ID: 28686510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 68Ga-DOTANOC PET/CT for baseline evaluation of patients with head and neck paraganglioma.
    Sharma P; Thakar A; Suman K C S; Dhull VS; Singh H; Naswa N; Reddy RM; Karunanithi S; Kumar R; Kumar R; Malhotra A; Bal C
    J Nucl Med; 2013 Jun; 54(6):841-7. PubMed ID: 23520216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of somatostatin receptor PET/CT using 68Ga-DOTANOC in gastrinoma patients with negative or equivocal CT findings.
    Naswa N; Sharma P; Soundararajan R; Karunanithi S; Nazar AH; Kumar R; Malhotra A; Bal C
    Abdom Imaging; 2013 Jun; 38(3):552-60. PubMed ID: 22743840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of (68)Ga-DOTANOC PET/CT imaging in a large exclusive population of pancreatic neuroendocrine tumors.
    Sharma P; Arora S; Dhull VS; Naswa N; Kumar R; Ammini AC; Bal C
    Abdom Imaging; 2015 Feb; 40(2):299-309. PubMed ID: 25134801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of 68Ga-DOTANOC PET/CT in patients with suspicion of neuroendocrine tumors: is its routine use justified?
    Sharma P; Arora S; Mukherjee A; Pal S; Sahni P; Garg P; Khadgawat R; Thulkar S; Bal C; Kumar R
    Clin Nucl Med; 2014 Jan; 39(1):37-43. PubMed ID: 24152621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ⁶⁸Ga-DOTANOC PET/CT in patients with carcinoma of unknown primary of neuroendocrine origin.
    Naswa N; Sharma P; Kumar A; Soundararajan R; Kumar R; Malhotra A; Ammini AC; Bal C
    Clin Nucl Med; 2012 Mar; 37(3):245-51. PubMed ID: 22310250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rare adult renal neuroblastoma better imaged by
    Jain TK; Singh SK; Sood A; Ashwathanarayama AG; Basher RK; Shukla J; Mittal BR
    Hell J Nucl Med; 2017; 20(1):100-101. PubMed ID: 28315919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (68)Ga-DOTANOC PET/CT detection of multiple extracranial localizations in a patient with anaplastic meningioma.
    Golemi A; Ambrosini A; Cecchi P; Ruiu A; Chondrogiannis S; Farsad M; Rubello D
    Rev Esp Med Nucl Imagen Mol; 2015; 34(4):258-60. PubMed ID: 25890891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Accessory Spleen Is an Important Pitfall of 68Ga-DOTANOC PET/CT in the Workup for Pancreatic Neuroendocrine Neoplasm.
    Rufini V; Inzani F; Stefanelli A; Castaldi P; Perotti G; Cinquino A; Indovina L; Rindi G
    Pancreas; 2017 Feb; 46(2):157-163. PubMed ID: 27846139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 68Ga-DOTANOC PET/CT allows somatostatin receptor imaging in idiopathic pulmonary fibrosis: preliminary results.
    Ambrosini V; Zompatori M; De Luca F; Antonia D; Allegri V; Nanni C; Malvi D; Tonveronachi E; Fasano L; Fabbri M; Fanti S
    J Nucl Med; 2010 Dec; 51(12):1950-5. PubMed ID: 21078794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of renal uptake of 68Ga-DOTANOC PET/CT and estimated glomerular filtration rate before and after peptide receptor radionuclide therapy in patients with metastatic neuroendocrine tumours.
    Kaewput C; Vinjamuri S
    Nucl Med Commun; 2016 Dec; 37(12):1325-1332. PubMed ID: 27612032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic osteomalacia: diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET/CT scan for the diagnosis and follow-up in one case.
    Dupond JL; Mahammedi H; Prié D; Collin F; Gil H; Blagosklonov O; Ricbourg B; Meaux-Ruault N; Kantelip B
    Bone; 2005 Mar; 36(3):375-8. PubMed ID: 15777669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-DOPA PET/CT and 68Ga-DOTANOC PET/CT scans as diagnostic tools in focal congenital hyperinsulinism: a blinded evaluation.
    Christiansen CD; Petersen H; Nielsen AL; Detlefsen S; Brusgaard K; Rasmussen L; Melikyan M; Ekström K; Globa E; Rasmussen AH; Hovendal C; Christesen HT
    Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):250-261. PubMed ID: 29116340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.